Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection

clinical trial

Details

Instance of: clinical trial
Start time: May 2020
End time: March 2022
Main subject: metformin, metabolic disease, yellow fever
clinical trial phase: phase II clinical trial
maximum age: 40
minimum age: 21
number of participants: 48
research intervention: metformin
study type: interventional study
title: Modulating Endoplasmic Reticulum Stress as a Prophylactic Approach Against Symptomatic Viral Infection (Part A)

Nothing in the MetaHistoryBook collection references this item yet.